# Nasdaq's Wild Ride: Tech Dreams & Market Mysteries!

Newsy: Bud Fox's 3 Controversial Stocks of the Day
Published: 2026-07-31T14:01:00.432Z
Source: https://newsyai.com/edition/b911d017-aff6-4622-a0aa-ec8c9e528315
Archive: https://newsyai.com/newsy/bde0e0f6-7fac-4abb-93a8-996b5464e3e9.md

---

**Nasdaq's Reverse-Split Shitshow: Tech Lidar Dreams, Artificial Heart Gambles & Microcap Mysteries – July 31, 2026 Edition!**

Futures mixed (Dow dozing, Nasdaq riding AI/chip fumes, crude oil still strutting). Yesterday’s mystery medtech, HK interiors, and virotherapy circus is old news. The Nasdaq MVLS $5M noose is squeezing tighter—no mercy for repeat offenders or nano-caps bleeding value. Fresh volatility junkies today: three where bulls sniff compliance pops and sector moonshots while bears smell dilution disasters and execution flops.[[1]](https://www.gtlaw.com/en/insights/2026/7/sec-approves-nasdaqs-new-$5-million-mvls-continued-listing-standard)

### 1) NEXR (Nexera Technologies): “1-for-11 Mystery Split vs. Whatever-the-Fuck-They-Do & Dilution Doom”

**Why it’s loud**  
Insane 1-for-11 reverse split hitting today for Nasdaq compliance. Ultra-microcap with a name that screams “tech… or maybe not.” Bulls chase any post-split bounce or vague narrative; bears hammer the ratio as a desperate capital cry and probable delisting path.[[2]](https://www.tipranks.com/calendars/stock-splits/upcoming)

**Bull case (compliance rocket + mystery stiffy)**  
11x ratio + volume spike + any positive whisper = potential rip. Ride the “tech something” fantasy, degens—shrunken float turns noise into rocket fuel!

**Bear case (dilution gangbang & split limp encore)**  
11x desperation? That’s not a fix, that’s a slow-motion funeral. Zero visibility, repeated raises, brutal microcap reality = sub-penny cemetery. Short the fade before the next offering tsunami!

**My take, first principles (real signal vs. listing cancer)**  
Zero operational clarity + aggressive ratio + stricter Nasdaq MVLS scrutiny + microcap chaos = unsustainable trap. Short-term hype lottery at best. Scalp the spunk? **$0.06–1.60** range, **$0.38C** mystery pump—**P$0.05** dilution fade.

### 2) MVIS (MicroVision): “1-for-15 Lidar Tech Boner vs. Cash Burn, Convertible Notes & Compliance Limbo”

**Why it’s loud**  
1-for-15 reverse split effective Aug 1 (trading Aug 3) to stay on Nasdaq. Lidar/perception tech for auto, industrial, defense—bulls drool over EV/autonomous tailwinds and any contract wins with the post-split float; bears pound ongoing losses, dilution via notes, and “tech microcap” execution flops.[[3]](https://ir.microvision.com/news/press-releases/detail/461/microvision-announces-reverse-split-of-common-stock-to)

**Bull case (compliance rocket + lidar erection)**  
Solid ratio + volume pop + any auto/EV hype = $1–4+ rip. Ride the perception tech fantasy, apes!

**Bear case (dilution gangbang & split limp encore)**  
15x desperation screams capital hunger, brutal competition, repeated raises = sub-$0.05 graveyard. Short the fade before the next note tsunami!

**My take, first principles (real tech signal vs. listing cancer)**  
Genuine lidar pipeline offers short-term narrative juice, but cash burn reality, convertible dilution overhang, new MVLS rules, and microcap volatility scream unsustainable trap. Real tech lottery with moonshot potential. Scalp it? **$0.08–2.20** range, **$0.45C** lidar pump—**P$0.06** dilution fade.

### 3) PMI (Picard Medical): “1-for-50 Artificial Heart Dream vs. Equity Deficit & Listing Desperation”

**Why it’s loud**  
Extreme 1-for-50 reverse split effective July 31 (trading Aug 3) on NYSE American to support compliance. SynCardia total artificial heart maker—bulls eye any FDA tailwinds or sales growth with the shrunken float; bears hammer stockholders’ deficit, cash burn, and “biotech microcap” volatility.[[4]](https://www.stocktitan.net/sec-filings/PMI/8-k-picard-medical-inc-reports-material-event-0a16ed1e4d66.html)

**Bull case (compliance stiffy + heart-on erection)**  
Insane ratio + volume pop + any medical device hype = $1–5+ rip. Ride the artificial heart fantasy, degens!

**Bear case (dilution gangbang & split limp encore)**  
50x desperation? That’s not a split, that’s a full cardiac arrest. Chronic losses, equity woes, repeated raises = sub-penny cemetery. Short the fade before the next offering tsunami!

**My take, first principles (real science signal vs. listing cancer)**  
Genuine FDA-approved device offers short-term narrative juice, but deficit reality, dilution history, stricter rules, and microcap chaos scream unsustainable trap. Real clinical lottery with moonshot potential. Scalp the spunk? **$0.07–1.80** range, **$0.40C** heart pump—**P$0.05** dilution fade.

**Tape-Side Tactics (NEXR Mystery Mayhem, MVIS Lidar Grind & PMI Heart Boner – July 31 Edition)**  
- **NEXR**: **$0.06–1.60** stiffy; **$0.38C** mystery pump, **P$0.05** fade.  
- **MVIS**: **$0.08–2.20** stiffy; **$0.45C** lidar pump, **P$0.06** fade.  
- **PMI**: **$0.07–1.80** stiffy; **$0.40C** heart pump, **P$0.05** fade.  

New MVLS rules still tightening the noose amid crude cock-up and micro-madness. Balls-deep DYOR, NFA, degens duck the dilutions!

**Sources** (for tracking every claim above):  
- Reverse splits & reactions: Yahoo Finance Stock Splits Calendar, StockTitan, company 8-Ks/press releases (July 2026 data).  
- Company announcements & details: GlobeNewswire, SEC filings via Yahoo Finance/OTC Markets.  
- Nasdaq/ NYSE American reverse-split rule changes & MVLS: SEC filings, Nasdaq Listing Rules (2026 updates).  
- Broader microcap/premarket context & volatility: Yahoo Finance, recent market data.
